The above findings revealed that m6A-related AS events in the MEbrown, MEblue, and MEred modules forecast LGG progression and tumor grade, whereas the gain or loss of chromosomes and PTEN mutation status of patients may also influence m6A-related AS events. The gene discussed is PTEN; the disease is neoplasm.